NASDAQ:ACRX
Delisted

Acelrx Pharmaceuticals Stock Signals

etoro logo Buy ACRX
*Your capital is at risk
$0.86
+0 (+0%)
At Close: Apr 08, 2024

Latest Data & Signals Issued

Below are some of the latest signals issued for AcelRx Pharmaceuticals

General

Signal Type Signal Value Data
Score 0.000 69 days ( -5.01 %
Last Price $0.86 0 %
Performance History
7 Days
$0.86 $0.86
0%
30 Days
$0.86 $0.86
0%
12 Mos
$0.615 $0.86
39.84%

5/18

Active Buy Signals

Specific Signals

Short Term
Net score: 25
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.86 - $0.86
Trend - 3 mos 0 % High Width: 0.00000000000010 %
Pred. range - 3 mos $0.86 - $0.86 Low 0 % - 0 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Apr 05, 2024 - 2 days
RSI Short Pivot Signal Sell Very Low Jan 23, 2024 - 53 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 54.33
Signal Type Signal Value Importance Data
Trend - 12 mos -9.77 % Very High Width: 200.35 %
Pred. range - 12 mos $0.370 - $1.11 High -57.03 % - 29.05 %
Short MA 12 mos Buy Very High Jan 02, 2024 - 67 days
Long MA 12 mos Buy Very High Dec 14, 2023 - 78 days
Short/Long MA 12 mos Buy Very High Dec 19, 2023 - 75 days
Pivot Long Sell Low Apr 05, 2024 - 2 days
RSI Long Pivot Signal Sell Low Feb 01, 2024 - 46 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT ACELRX PHARMACEUTICALS
AcelRx Pharmaceuticals
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pai...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE